Inbiomotion has published the results of a Phase III study looking at its MAFTest to personalized approaches to the disease. Inbiomotion, based in Barcelona’s¬†biotech hub, works on a highly selective biomarker for breast cancer. A Phase III study demonstrated that …

This awesome article Personalized Breast Cancer Treatment Coming Soon with Help from Spanish Biotech appeared first on Labiotech.eu. Be kind and don’t copy it without asking ūüėČ



Source link